- Home
- PSN vs LNTH Comparison
PSN vs LNTH Comparison
Compare PSN & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSN
- LNTH
- Stock Information
- Founded
- PSN 1944
- LNTH 1956
- Country
- PSN United States
- LNTH United States
- Employees
- PSN N/A
- LNTH N/A
- Industry
- PSN EDP Services
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- PSN Technology
- LNTH Health Care
- Exchange
- PSN Nasdaq
- LNTH Nasdaq
- Market Cap
- PSN 6.8B
- LNTH 7.5B
- IPO Year
- PSN 2019
- LNTH 2015
- Fundamental
- Price
- PSN $67.92
- LNTH $74.75
- Analyst Decision
- PSN Buy
- LNTH Strong Buy
- Analyst Count
- PSN 11
- LNTH 5
- Target Price
- PSN $87.44
- LNTH $133.80
- AVG Volume (30 Days)
- PSN 1.6M
- LNTH 1.5M
- Earning Date
- PSN 04-30-2025
- LNTH 05-07-2025
- Dividend Yield
- PSN N/A
- LNTH N/A
- EPS Growth
- PSN 50.29
- LNTH N/A
- EPS
- PSN 2.35
- LNTH 3.53
- Revenue
- PSN $6,769,260,000.00
- LNTH $1,536,699,000.00
- Revenue This Year
- PSN $5.09
- LNTH $4.63
- Revenue Next Year
- PSN $4.47
- LNTH $9.35
- P/E Ratio
- PSN $29.02
- LNTH $21.17
- Revenue Growth
- PSN 16.61
- LNTH 12.53
- 52 Week Low
- PSN $54.56
- LNTH $73.11
- 52 Week High
- PSN $114.68
- LNTH $126.89
- Technical
- Relative Strength Index (RSI)
- PSN 58.96
- LNTH 26.90
- Support Level
- PSN $66.51
- LNTH $77.01
- Resistance Level
- PSN $69.46
- LNTH $81.50
- Average True Range (ATR)
- PSN 1.75
- LNTH 3.48
- MACD
- PSN 0.24
- LNTH -1.42
- Stochastic Oscillator
- PSN 78.14
- LNTH 4.58
About PSN Parsons Corporation
Parsons Corp is a provider of technology-driven solutions in the defense, intelligence, and critical infrastructure markets. The business activities of the group are carried out through Federal Solutions and Critical Infrastructure segments. The Federal Solutions segment is a high-end service and technology provider to the U.S. government, delivering timely, cost-effective solutions for mission-critical projects, whereas the Critical Infrastructure segment provides integrated design and engineering services for complex physical and digital infrastructure around the globe.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.